Around 150 experts from various stakeholder groups—including a number of scientists from the network of the German Center for Infection Research (DZIF)—have developed a roadmap for improving
The German Center for Infection Research (DZIF) is again offering the DZIF Prize for Translational Infection Research. Scientists can apply to the DZIF Academy until 6 October 2024. A prize of 5,000
The microbiome, i.e. the microorganisms that colonise our gut and help with digestion, weighs around one and a half kilograms. It consists primarily of bacteria and also has a protective effect
Members of Parliament (MPs) from the CDU, FDP, SPD and Die Linke parties have joined forces in a parliamentary group to focus more on combating antimicrobial resistance in the future.
HYpharm's innovative preventive agent HY-133 has reached the first clinical trial phase. HY-133 is specifically effective against the bacterial pathogenStaphylococcus aureus including multi-resistant
On 1 June 2024, Professor Marcus Altfeld, Coordinator of the research area HIV at the German Center for Infection Research (DZIF), became Scientific Director of the Leibniz Institute of Virology (LIV)
Prof. Dr Christoph Ernst from the Institute of Medical Microbiology, Immunology and Hygiene at the University Hospital of Cologne and the Faculty of Medicine has been selected for the Boehringer
According to estimates, 4.95 million deaths worldwide in 2019 were directly or indirectly attributable to infections with resistant bacteria. The rising number of resistant bacterial pathogens, also
A team led by Prof Achim Hoerauf in the German Center for Infection Research (DZIF) is further developing the antibiotic corallopyronin A as a treatment for the neglected tropical diseases river
Please use image only in connection with this press release.
Most antibiotics used in human medicine originate from natural products derived from bacteria and other microbes. Novel microorganisms are therefore a promising source of new active compounds—also for
